Impact of Viz LVO on Time-to-Treatment and Clinical Outcomes in Large Vessel Occlusion Stroke Patients Presenting to Primary Stroke Centers

Jacob R. Morey, MBA; Emily Fiano, MPH; Kurt A. Yaeger, MD; Xiangnan Zhang, MS; Johanna T. Fifi, MD

Randomized controlled trials have demonstrated the importance of time-to-treatment on clinical outcomes in large vessel occlusion (LVO) stroke. 

Viz LVO offers a technological solution to enable early notification of the PSC stroke team and affiliated neurointerventional team and to improves times to treatment and patient outcomes in patients with large vessel occlusions.

Download the article to learn more.